ADLM 2025 Draws Nearly 16,500 Attendees with Focus on Health, AI, and Misinformation
The Association for Diagnostics & Laboratory Medicine (ADLM) hosted its 2025 meeting in Chicago from July 27-31, bringing together almost 16,500 professionals from the clinical laboratory field. The event highlighted advancements that help healthcare providers diagnose and treat patients more effectively.
Keynote Presentations Highlight Emerging Issues
The conference featured five plenary talks by leading experts. Dr. Heidi Rehm, the 2025 Wallace H. Coulter Lectureship awardee, kicked off the event by discussing the integration of genomic data into clinical decision-making and the global collaboration needed to achieve this goal.
Dr. Judy Wawira Gichoya addressed the challenges of adopting artificial intelligence in healthcare, emphasizing the role of clinical labs in overcoming these obstacles. Timothy Caulfield tackled the issue of medical misinformation, offering practical strategies to counteract false health narratives.
Dr. Jack Gilbert shared insights into how microbiome research, combined with AI and multi-omic approaches, is advancing personalized medicine. The closing keynote by Dr. Leonardo Trasande explored the health risks posed by PFAS (per- and polyfluoroalkyl substances), highlighting the potential need for changes in laboratory medicine and patient care.
Innovations Recognized with Disruptive Technology Award
The Disruptive Technology Award competition showcased novel diagnostic tools aimed at improving patient care. Rarity Bioscience won with their superRCA technology, an ultrasensitive test capable of detecting rare cancer-causing mutations in blood or tissue samples.
Clinical Lab Expo Exhibits Latest Diagnostic Technologies
The expo featured nearly 800 exhibitors across 240,402 net square feet, displaying innovations in AI, molecular diagnostics, clinical microbiology, automation, point-of-care testing, and mass spectrometry. This provided attendees with a broad view of current and upcoming laboratory technologies.
Industry Perspectives
Mark J. Golden, ADLM CEO, emphasized the critical role of laboratory medicine in addressing healthcare challenges such as AI integration and misinformation. He noted that ADLM 2025 created valuable opportunities for knowledge exchange and collaboration, reinforcing the lab community's central position in advancing health outcomes.
Looking Ahead
ADLM 2026 is scheduled for July 26-30 in Anaheim, California, promising continued focus on innovations that support clinical laboratories and healthcare providers.
About ADLM
ADLM unites over 70,000 clinical laboratory professionals, physicians, researchers, and business leaders from more than 110 countries. Since 1948, it has supported advances in fields such as clinical chemistry, molecular diagnostics, mass spectrometry, clinical microbiology, and data science. The organization promotes collaboration and knowledge sharing to improve patient care globally.
For those interested in expanding their expertise in artificial intelligence and its applications in healthcare, exploring resources like Complete AI Training can provide practical courses and certifications tailored to healthcare professionals.
Your membership also unlocks:
